PMC2018 Mobile Header 300x76

Best Practice Guidelines for HPV Prevention and Cervical Cancer Screening

Type: Session
Therapeutic: Immunization,Infectious Disease,Pediatrics,Screening & Prevention,Women's Health,Men's Health
Saturday May 12
8:30am to 9:30am
Location: Lecture Hall 1
Credits: 1 Mainpro+

  • Description

    Human Papilloma Virus is now recognized to cause disease in both females and males, affecting the cervix, vulva, vagina, anal epithelium and oropharyngeal cavity. HPV vaccines that reduce infection and disease have been available for over a decade and recommendations have evolved to become gender neutral. The evidence for such broad recommendations will be discussed. Changes to the Ontario Cervical Screening Guidelines and HPV testing for primary care providers will be reviewed. The participant will learn about tools and resouces available to assist them in counseling of patients with HPV related diseases.

    Learning Objectives
    • Discuss evidence for gender neutral HPV vaccination to prevent disease of lower genital tract and oropharyngeal cavity.
    • Review Ontario Cervical Screening Guidelines and highlight proposed changes for primary care providers including HPV testing.
    • Identify helpful tools that assist in counseling patients for HPV vaccination, HPV related diseases and referrals to colposocpy.

  • Speakers